By harnessing the power of a GLP-1, GIP, and glucagon receptor agonist simultaneously, this medication is being studied for effects on appetite, metabolic signaling, and energy balance
A review of the logistic role of L-carnitine in the management of radiation toxicity and radiotherapy side effects
There is increasing evidence for the use of bariatric surgery in patients with a BMI of less than 35 kg per m 2 , and the adjustable gastric band system has been approved for use in patients with a BMI of 30 to 34.9 kg per m 2 who have obesity-related conditions
Triple-hormone-receptor agonist retatrutide for obesity: A phase 2 trial
Keep refrigerated where applicable
En contextos mdicos, se ha estudiado para tratar ciertas condiciones metablicas, fatiga crnica, envejecimiento celular y enfermedades neurodegenerativas, aunque su eficacia puede variar segn la forma en que se administre y las necesidades individuales